Takeda (NYSE:TAK) (4502.T) said on Monday that the European Commission approved Pfizer (NYSE:PFE) and the company's ...

The European Commission (EC) has approved Takeda's antibody-drug conjugate (ADC) Adcetris (brentuximab vedotin) plus the ...

TOKYO -- U.S. proxy advisory firm Institutional Shareholder Services (ISS) is recommending shareholders vote against the ...

Takeda Pharmaceutical Company Limited (NYSE:TAK)’s ADCETRIS® (brentuximab vedotin) in combination with ECADD was authorized ...

This is the web version of STAT’s special newslette r from the annual meeting of the American Society of Oncology. For more ...

US drugmaker Protagonist Therapeutics (Nasdaq: PTGX) and Japan’s Takeda Pharma (TYO:4502) announced detailed results from the ...

Defending champion Yuka Saso's bid for a third U.S. Open title in five seasons got off to a rocky start with a 2-over-par 74.

"I am extremely proud that Takeda has been recognized as one of the top ten employers in the world for 2024. This confirms ...

Toriyama humbled his editor one day when Takeda visited his new house and noticed something absolutely unbelievable that he ...

Takeda (TSE:4502/NYSE:TAK) today announced that applications are now open for its Innovators in Science Award. This prestigious global award, originally launched in 2016, celebrates groundbreaking ...

Japanese rookie Rio Takeda finished tied for second at the U.S. Women's Open on Sunday as overnight leader Maja Stark of Sw ...

The Call for Applications is now open at https://www.innovatorsinscienceaward.com/ and will remain open through September 16, 2025. Shortlisted applicants will be announced in January 2026 and ...